The African cancer burden: what is the potential role of modern oncology innovation in reducing the continent's rapidly rising mortality?

Postgrad Med J. 2023 Aug 22;99(1175):941-945. doi: 10.1093/postmj/qgad043.

Abstract

With increasing prevalence and an expected rise in disease burden, cancer is a cause of concern for African healthcare. The cancer burden in Africa is expected to rise to 2.1 million new cases per year and 1.4 million deaths annually by the year 2040. Even though efforts are being made to improve the standard of oncology service delivery in Africa, the current state of cancer care is not yet on par with the rise in the cancer burden. Cutting-edge technologies and innovations are being developed across the globe to augment the battle against cancer; however, many of them are beyond the reach of African countries. Modern oncology innovations targeted to ward Africa would be promising to address the high cancer mortality rates. The innovations should be cost-effective and widely accessible to tackle the rapidly rising mortality rate on the African continent. Though it may seem promising, a multidisciplinary approach is required to overcome the challenges associated with the development and implementation of modern oncology innovations in Africa.

Keywords: Africa; innovation; mortality; oncology.

MeSH terms

  • Africa / epidemiology
  • Cost of Illness
  • Delivery of Health Care*
  • Global Health
  • Humans
  • Neoplasms* / therapy